ANA ISABEL SÁNCHEZ FRUCTUOSO-rekin lankidetzan egindako argitalpenak (8)

2020

  1. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients

    Nefrologia, Vol. 40, Núm. 3, pp. 265-271

2019

  1. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

2013

  1. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

  2. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

2012

  1. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: The AnemiaTrans study

    Advances in Therapy, Vol. 29, Núm. 11, pp. 979-991

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2008

  1. Recomendaciones para la indicación, obtención, procesamiento y evaluación de biopsias en el trasplante renal

    Nefrologia, Vol. 28, Núm. 4, pp. 385-396

2006

  1. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

    Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658